Colgate-Palmolive (CL) April weekly option implied volatility into quarter results

Go back to Colgate-Palmolive (CL) April weekly option implied volatility into quarter results

Colgate-Palmolive Company (CL) PT Raised to $98 at Deutsche Bank

April 29, 2024 9:56 AM EDT

Deutsche Bank analyst Steve Powers raised the price target on Colgate-Palmolive Company (NYSE: CL) to $98.00 (from $94.00) while maintaining a Buy rating.

The analyst comments "Looking ahead, CL reiterated its full-year adjusted EPS outlook (+MSD-HSD growth), baking in sufficient conservatism, in our view, and... More

Colgate-Palmolive Company (CL) PT Raised to $100 at BofA Securities

April 29, 2024 7:03 AM EDT

BofA Securities analyst Brian Spillane raised the price target on Colgate-Palmolive Company (NYSE: CL) to $100.00 (from $90.00) while maintaining a Buy rating.

The analyst comments "CL opened the year with organic sales growth of +9.8% and high-quality EPS of $0.86 vs our $0.82 forecast. Pricing growth of +8.5%... More

Colgate-Palmolive Company (CL) PT Raised to $95 at RBC Capital

April 29, 2024 6:35 AM EDT

RBC Capital analyst Nik Modi raised the price target on Colgate-Palmolive Company (NYSE: CL) to $95.00 (from $88.00) while maintaining a Sector Perform rating.

The analyst comments "Another impressive print for CL, displaying robust topline growth with upside coming from pricing and volume. Margin strength was... More

Colgate-Palmolive Company (CL) PT Raised to $92 at Wells Fargo

April 29, 2024 5:48 AM EDT

Wells Fargo analyst Chris Carey raised the price target on Colgate-Palmolive Company (NYSE: CL) to $92.00 (from $90.00) while maintaining a Equal Weight rating.

The analyst comments "Most angles of CL valuation will show it at the highest relative premiums to HPC peers... More